Dear blog readers,

Unfortunately, I am still having several blog-IT issues and it might take a while to fix it (being a non-tech that I am). An “alternative fact” is that the Trump Administration is now shutting down environment-related blogging sites based in the US. 🙂

In the meantime, I hope you were able to get this post via email.

This is the first time I have heard of Biotensidon and I have already spoken to them about their plans for a new rhamnolipid commercial production in Germany. All information from the interview is available for subscribers of Tecnon OrbiChem’s Biomaterials newsletter. Biotensidon, a German biotech company, announced that it has developed a technology enabling a cost-effective commercial production of rhamnolipids.

An investor has reportedly injected a double-digit million Euros in the company, and Biotensidon plans to use the capital influx to build a facility in Germany with an annual output of 5 ktpa producing a new rhamnolipid supra molecular complex under the trade name Raphynal. Initial applications include animal feed, fertilizers, detergents, degreasing products and fire-extinguishing foams as well as cosmetics and pharmaceuticals.

Biotensidon’s current rhamnolipid yield is said to be at above 30 g/liter. Production is expected to start this year with initial capacity of 200 tons. expanding to 2,000 tons by 2018, and plans to reach 5,000 tons by 2019.

For more rhamnolipid or glycolipid articles, just use the search bar on the upper left section of the blog.